Capricorn invests in C-Lecta

The value of the funding round was not disclosed, but the vehicles used by Capricorn generally invest between €5-20m. C-Lecta reported revenues between €10-20m in 2017, according to a corporate information portal.

Capricorn drew capital from two funds for the investment: Capricorn Sustainable Chemistry Fund, and Quest for Growth.

German VC BMT also took part in the financing via its MFT Mittelstands Fonds vehicle.

The fresh funding will be used to further develop its pipeline projects.

Previous funding
High-Tech Gründerfonds invested €600,000 in C-Lecta's seed round in January 2006. The VC also took part in a funding round alongside life sciences investor SHS Gesellschaft für Beteiligungsmanagement in October 2008 at an undisclosed valuation.

Company
C-Lecta is a biotechnology company headquartered in Leipzig and founded in 2003. It focuses on enzyme engineering and application in regulated markets like food and pharma. The company recently announced a breakthrough in the development of a plant-based food sweetener. It employs 60 people.

People
Capricorn Venture Partners – Ludwig Goris (investment manager).
BMT – Kevin Reeder (CEO).
C-Lecta – Marc Struhalla (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• DACH
• Healthcare
• Germany
• Venture